Archive for the ‘Arizona Bioscience’ Category
TUCSON, Ariz.–(BUSINESS WIRE)–Ventana Medical Systems, Inc. (NASDAQ: VMSI) today announced it will release its third quarter 2007 financial and operating results on Thursday, October 18, 2007 after the market closes.
Christopher Gleeson, President and Chief Executive Officer, and Lawrence Mehren, Chief Financial Officer, will host a conference call and webcast to discuss these results and Ventana’s future outlook on Thursday, October 18, 2007 at 5:30 p.m. (ET). Read the rest of this entry »
PHOENIX–(BUSINESS WIRE)–Tessenderlo Kerley, Inc.’ (TKI) NovaSource division announced today that Bob Gestring has joined the company as Midwest Regional Account Manager. Gestring’ responsibilities will include the current Sectagon® business and the identification and evaluation of new business opportunities for NovaSource. His geographic area includes the Dakotas, Minnesota, Wisconsin, Michigan, Ohio, Illinois, Indiana, Iowa and Nebraska. Read the rest of this entry »
PHOENIX–(BUSINESS WIRE)–Tessenderlo Kerley, Inc.’s (TKI) NovaSource division announced today, Rita McDannald has joined the company as Sales Service Manager based in the Phoenix office. McDannald’s customer service and administrative responsibilities will include the NovaSource products including Sectagon®.
McDannald joins NovaSource from BASF where she spent ten years in sales support and customer service. Read the rest of this entry »
TUCSON, Ariz.–(BUSINESS WIRE)–High Throughput Genomics, Inc., a provider of novel microplate-based gene expression assay technology and services for the pharmaceutical and life sciences industries, today announced a collaboration agreement with the University of California, San Diego, Department of Medicine, Division of Endocrinology and Metabolism. Under the terms of the agreement, HTG and UCSD will collaborate to generate novel arrays using tissue samples from mice as well as various cell lysates to evaluate genes responsible for inflammation and insulin production using HTG’s qNPA™ quantitative Nuclease Protection Assay technology. Dr. Jerry Olefsky is the lead collaborator on the project for UCSD. Read the rest of this entry »
ASU’s Biodesign Institute has received new funding to continue in its development of novel DNA sequencing technologies to help usher in the era of personalized medicine.
Looking ahead to a time when each person’s genome can be sequenced as a routine part of medical research and health care, the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), awarded more than $15 million in grants to support development of innovative technologies with the potential to dramatically reduce the cost of DNA sequencing. Read the rest of this entry »
Multi-Year Agreement Supports Field Tests of Transgenic Guayule to Improve Rubber and Biomass Yields
MARICOPA, Ariz.–(BUSINESS WIRE)–Yulex® Corporation, the United States Department of Agriculture’s Agricultural Research Service (USDA-ARS), and Mendel Biotechnology have signed an agreement to develop and field test proprietary guayule (why-YOU-lee) plants with enhanced natural rubber latex yields and increased biomass. Read the rest of this entry »
Paths to Licensing and Commercialization for Life Science Companies
Session Highlights:
* Session 1: Applied Research: The Translational Bridge Between Lab & Marketplace
Panel Discussion: Cognitive Disorders Due to Neuro-Degenerative Diseases
* Session 2: Technology Transfer & Licensing
Panel Discussion: The Relationship Between Researchers and Tech Transfer Offices
* Session 3: Challenges Confronting the “Start-Up” Private Sector Company
Panel Discussion: Key Capital Formation Issues Confronting Start-Ups
Other Conference Highlights:
* Registration & Continental Breakfast
* Welcome & Opening Remarks
* Opening Keynote Speaker
* Luncheon with Keynote Speaker
* Reception
When: Thursday, October 18, 2007
Location: Wyndham, Downtown Phoenix
Cost: $99
To register, visit www.asutechnopolis.org.
The 3rd Annual Commercializing Arizona Life Sciences Forum is presented by ASU Technopolis and Jennings, Strouss & Salmon PLC, and sponsored by Arizona Department of Commerce, Enable Ventures, City of Phoenix, Insys Therapeutics, Mayo Clinic and Sun Health.
Karen Katzorke
Program Specialist, ASU Technopolis
www.asutechnopolis.org
www.investsouthwest.org
Educating, Coaching and Connecting Entrepreneurs and Innovators
Remarkable Whole Food Product Used to Control Diabetes Will Now Be Available with Streamlined Online Service
SCOTTSDALE, Ariz.–(BUSINESS WIRE)–eFoodSafety.com, Inc. (OTCBB:EFSF) today announced that for those suffering from diabetes and related blood sugar problems, Cinnergen™, a product based on natural food services, which helps control blood sugar levels, will now be available on a host of retail websites at affordable prices, featuring streamlined shipping. Read the rest of this entry »
PRESCOTT, Ariz.–(BUSINESS WIRE)–Vortex Corporation, a global innovator of chemical-free water and air purification products for consumer and commercial use, announced that it has been awarded a $250,000 enhancement to its current U.S. Department of Homeland Security (DHS) Advanced Research Projects Agency Small Business Innovation Research (HSARPA SBIR) contract. As a follow on to two other contracts DHS awarded Vortex within the last two years, the $250,000 contract is for the continued testing and development of chlorine-free water purification systems for municipal drinking water use. The contract supports a field trial with a major U.S. water utility, designed to prove the efficacy and robustness of the Vortex system with ground water sources containing challenging microorganisms such as Adenoviruses and Naegleria fowleri. Read the rest of this entry »

